Rising hospitalization rate for compensated and decompensated cirrhosis in the United States

被引：0
|
作者：
Derosa, Vincent P.
Jamal, M. mazen
机构：
来源：
GASTROENTEROLOGY | 2007年 / 132卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A744 / A744
页数：1
相关论文
共 50 条
  • [1] Prognostic factors in compensated and decompensated cirrhosis
    Ripoll C.
    Zipprich A.
    Garcia-Tsao G.
    Current Hepatology Reports, 2014, 13 (3) : 171 - 179
  • [2] The Rising Healthcare Burden of Alcoholic Cirrhosis in the United States
    Mellinger, Jessica L.
    Shedden, Kerby
    Tapper, Elliot B.
    Winder, Gerald S.
    Adams, Megan A.
    Fontana, Robert J.
    Volk, Michael
    Blow, Frederic
    Lok, Anna S.
    HEPATOLOGY, 2017, 66 : 94A - 94A
  • [3] Outcomes for Patients on DOACs in Compensated and Decompensated Cirrhosis
    Aslam, Aysha
    Gombar, Saurabh
    Kwo, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S893 - S894
  • [4] ERYTHROPOIETIN RESPONSE TO ANEMIA IN COMPENSATED AND DECOMPENSATED CIRRHOSIS
    SICILIANO, M
    TOMASELLO, D
    MILANI, A
    ROSSI, L
    HEPATOLOGY, 1994, 20 (04) : A399 - A399
  • [5] SURVIVAL AND PROGNOSTIC INDICATORS IN COMPENSATED AND DECOMPENSATED CIRRHOSIS
    DAMICO, G
    MORABITO, A
    PAGLIARO, L
    MARUBINI, E
    DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (05) : 468 - 475
  • [6] HEXOBARBITAL DISPOSITION IN COMPENSATED AND DECOMPENSATED CIRRHOSIS OF LIVER
    ZILLY, W
    BREIMER, DD
    RICHTER, E
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1978, 23 (05) : 525 - 534
  • [7] Prognostic indicators of survival in patients with compensated and decompensated cirrhosis
    Zipprich, Alexander
    Garcia-Tsao, Guadalupe
    Rogowski, Sebastian
    Fleig, Wolfgang E.
    Seufferlein, Thomas
    Dollinger, Matthias M.
    LIVER INTERNATIONAL, 2012, 32 (09) : 1407 - 1414
  • [8] Alteration of micronutrient status in compensated and decompensated liver cirrhosis
    Kar K.
    Dasgupta A.
    Vijaya Bhaskar M.
    Sudhakar K.
    Indian Journal of Clinical Biochemistry, 2014, 29 (2) : 232 - 237
  • [9] Empagliflozin is safe and tolerable in patients with compensated or decompensated cirrhosis
    Shen, I.
    Danta, M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 : 66 - 67
  • [10] MULTIPLE CHRONIC CONDITIONS AND MORTALITY IN COMPENSATED AND DECOMPENSATED CIRRHOSIS
    Fallahzadeh, Mohammad Amin
    Hall, Lauren
    Ogola, Gerald
    Izzy, Manhal
    Reddy, Vikrant
    Asrani, Sumeet K.
    HEPATOLOGY, 2021, 74 : 55A - 55A
12345